Outset Medical, Inc. (NASDAQ:OM) Q4 2022 Earnings Conference Call February 13, 2023 5:00 PM ET

Company Representatives

Leslie Trigg - Chair, Chief Executive Officer

Nabeel Ahmed - Chief Financial Officer

Jim Mazzola - Head of Investor Relations

Conference Call Participants

Travis Steed - Bank of America

Rick Weiss - Stifel

Shagun Singh - RBC Capital Markets

Suraj Kalia - Oppenheimer

Drew Ranieri - Morgan Stanley

Operator

Good day, and thank you for standing by. Welcome to the Outset Medical Q4 2022 Earnings Conference Call. At this time all participants are in a listen-only mode. After the speakers' presentation, there will be a question-and-answer session. [Operator Instructions]. Please be advised that today's conference is being recorded.

I would now like to hand the conference over to Jim Mazzola, Head of Investor Relations. Please go ahead.

Jim Mazzola

Thank you and good afternoon, everyone. Welcome to our fourth quarter and full year 2022 earnings call. Here with me today are Leslie Trigg, Chair and Chief Executive Officer; and Nabeel Ahmed, Chief Financial Officer. During the call we will discuss our fourth quarter and 2022 operational and financial results, provide an update on our outlook, and host a question-and-answer session.

We issued a news release and filed an 8-K after the close of market today and updated our investor presentation, all of which can be found on the investor pages of www.outsetmedical.com. This call is being recorded and will be archived in the Investors section of our website.

It is our intent that all forward-looking statements made during today's call will be protected under the Private Securities Litigation Reform Act of 1995. These statements relate to expectations or predictions of future events, are based on our current estimates and various assumptions, and involve material risks and uncertainties that could cause actual results or events to materially differ from those anticipated or implied.

Outset assumes no obligation to update these statements. For a list and description of the risks and uncertainties associated with our business, please refer to the Risk Factors section of Outset's public filings with the Securities and Exchange Commission, including our latest annual and quarterly reports.

And with that, let me turn the call over to Leslie.

Leslie Trigg

Thanks, Jim. Good afternoon, everyone, and thank you for joining us. We're very pleased with our performance in the fourth quarter, which capped off an important year for Outset.

During 2022, we significantly increased the number of Tablo Consoles in hospitals and homes, surpassed 1 million treatments and helped health care providers continue to deliver exceptional lower cost care in a challenging labor environment. We also fundamentally strengthened our platform for growth by innovating and extending Tablo's technological advantages, adding key talent and strengthening our balance sheet.